Member Info for Wiggly

Well it cant be Innova as their LFT is a 30 minute result?. Can you post pic of email?

AS did mention sites were being established to support clinical validation.

All I know is that Al said yesterday preparing for large scale clinical validation and a number of sites had been identified.

Bump.

Anyone care to comment? I think this opens the door for avct to bid?

According to Al yesterday... Which means

We must have passed futility test (Phase 2) of Porton Down 4 Phase procedure, as you can only start clinical evaluation on Phase 3a and Phase 3b once Phase 2 is complete. Yesterday the RNS makes it clear that we are starting clinical evaluation

Agree, if it is confirmed AVCT are bidding for this tender then I think you can also assume that AVCT WILL WIN a significant portion of the award.

I think there is a real chance AVCT will be bidding.

100% being teed up for avct.

The word Affimer has been used as it has clearly been pre qualified.

Why else would it be mentioned???

There could be multiple other techs out there that could be used but they have not been qualified.

Here here zeremy.

Very nice find. I think there is a now a decent chance that we are bidding for this tender which in itself is massive. Tender delayed to accommodate avct?

Are they efficient against the Munk mutant Strain?

Can avct produce Affimers to target the spike from the mutant strain?

Much like flu, I think there is a high chance that CV will mutate and the current vaccines will lose efficiency.

It is possible that mass testing around this time of year may persist for years and years.

Totally agree. Can we do anything about this?

At what point did bbi switch from working on TT to working on a development product?

What exactly are Abington now working on?? TT on the cytiva product or Tt on the bbi product?

Why can't Al be 100% clear on things.

Dissapointed.

Pl75

'However, they could have been honest about this a while back, this hasn’t just happened today. I’m not impressed and I’m disappointed as it looks like timescales have slipped'

Sir Al was pumping the shareprice while house hunting.

He should resign.

As a ceo he has missed multiple deadlines and now has more uturns than Boris.

I'm not concerned about the short term shareprice reaction as believe the tech speaks for itself. We do however need a ceo that can commercialise ASAP.

Spike, you could be correct. There was also a change of language recently with reference to A rapid antigen test... Not THE rapid antigen test

I don't think this RNS was necessary today, but perhaps by sharing all of the latest market information, it clears the decks for the Directors to load up?

BAMS alone is enough to deliver significant value for shareholders and it is very close.

If we drop today's its another huge buying opp.

Unfortunately we will get taken out before we see 200.

We now know the selling price is usd 12.5 PER REACTION/ TEST. How much of this do you think will makes its way to AVCT?

She has responded.

Another advantage for BAMS vs pcr is that it can also test for flu

And finally, we ran our first patient samples today, results are looking very good. ????And we have currently packed 75 at home test kits!! 425 to go.